Complex karyotype including chromosomal translocation (8;14) (q24;q32) in one case with B-cell prolymphocytic leukemia

Leukemia Research

Volumn 31, Issue 5, 2007, Pages 699-701

  Crisostomo, Ricardo H ^a   Fernandez, Jose A ^a   Caceres, William ^a  

^a San Juan City Hospital   (Puerto Rico)

Author keywords

14); B cell prolymphocytic leukemia; Cytogenetic; Immunophenotyping; t(8

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HLA DR ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; PREDNISONE; VINCRISTINE;

ADULT; ANEMIA; ARTICLE; B CELL LEUKEMIA; B CELL PROLYMPHOCYTIC LEUKEMIA; BLOOD SMEAR; BONE MARROW BIOPSY; CASE REPORT; CELL STRUCTURE; CHROMATIN; CHROMOSOME TRANSLOCATION 8; COMBINATION CHEMOTHERAPY; CYTOGENETICS; FEMALE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE 45,X; KARYOTYPE 46,XX; LEUKEMIA REMISSION; LEUKOCYTOSIS; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; PROLYMPHOCYTE; PROLYMPHOCYTIC LEUKEMIA; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, B-CELL; LEUKEMIA, PROLYMPHOCYTIC; MIDDLE AGED; PREDNISONE; TRANSLOCATION, GENETIC; VINCRISTINE;

EID: 34147178792     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.06.010     Document Type: Article

References (18)

1. Melo J.V., Catovsky D., and Gallon D.A. The relationship between chronic lymphocytic leukemia and prolymphocytic leukaemia. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol 63 (1986) 377-387
2. Matutes E., and Polliack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Din Exp Hematol 4 (2000) 22-47
3. Lens D., Matutes E., Catovsky D., et al. Frequent deletions at 11q23 and 13ql4 in B-cell prolymphocytic leukemia (B-PLL). Leukemia 14 (2000) 427-430
4. Lens D., de Schouwer P.J., Hamoudi R.A., et al. p53 abnormalities in B-cell prolymphocytic leukemia. Blood 89 (1997) 2015-2023
5. Juliusson G., and Gahrton G. Cytogenetics in CLL and related disorders. Bailliere Clin Haem 6 4 (1993) 821-848
6. Kuriakose P., Perveen N., Maeda K., et al. Translocation (8; 14) (q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia. Cancer Genet Cytogenet 150 (2004) 156-158
7. Merchant S., Schlette E., Sanger W., et al. Mature B-cell leukemias with more than [55%] prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med 127 (2003) 305-309
8. Scott C.S., Limbert H.J., Roberts B.E., and Stark A.N. Prolymphocytoid variants of chronic lymphocytic leukemia: an immunological and morphological survey. Leuk Res 11 (1987) 135-140
9. Ruchlemer R., Parry-Jones N., Brito-Babapulle V., et al. B-prolymphocytic leukemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukemia. Br J Haematol 125 (2004) 330-336
10. Rosenwald A., Staudt L.M., Duyster J.G., and Morris S.W. Molecular aspects of non-hodgkin lymphomagenesis. Wintrobe's clinical hematology (2004), Williams & Wilkins, Lippincott p. 2326-61
11. Blackwood E.M., and Eisenman R.N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251 (1991) 1211-1217
12. Prendergast G.C., Lawe D., and Ziff E.B. Association of Myn, The murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65 (1991) 395-407
13. Grandori C., Mac J., Siebelt F., et al. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J 15 (1996) 4344-4357
14. Mateyak M.K., Obaya A.J., and Sedivy J.M. C-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 19 (1999) 4672-4683
15. Wu K.J., Grandori C., Amacker M., et al. Direct activation of TERT by c-MYC. Nat Genet 21 2 (1999) 220-224
16. Shvidel L., Shalrid M., Bassous L., et al. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leukemia Lymphoma 33 (1999) 169-179
17. Melo J.V., Catovsky D., Gregory W.M., et al. The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia. Br J Haematol 65 (1987) 23-29
18. Cheson B.D., Bennett J.M., Rai K.P., et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-Sponsored Working Group. Am J Hematol 29 (1988) 152-163